| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 484,036 | 450,683 | 435,100 | 525,691 | | Cost of Revenue | 369,991 | 340,538 | 329,298 | 405,443 | | | Gross Profit | 114,045 | 110,145 | 105,802 | 120,248 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 37,739 | 35,847 | 36,422 | 38,622 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 76,306 | 74,298 | 69,380 | 81,626 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,315 | 1,161 | 341 | 992 | | Earnings Before Interest And Taxes | 78,389 | 76,225 | 70,604 | 82,640 | | Interest Expense | 1,714 | 2,208 | 2,381 | 3,603 | | Income Before Tax | 76,675 | 74,017 | 68,223 | 79,037 | | Income Tax Expense | 26,836 | 25,906 | 23,878 | 28,028 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 52,256 | 48,111 | 44,345 | 51,009 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,839 | 48,111 | 44,345 | 51,009 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $49,839 | $48,111 | $44,345 | $51,009 |
|
0.01% Nasdaq 
Income Statement
